Plus Therapeutics (NASDAQ:PSTV) Given Hold Rating at D. Boral Capital
D. Boral Capital reissued their hold rating on shares of Plus Therapeutics (NASDAQ:PSTV – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a $9.00 price target on the stock. Several other research firms have also issued reports on PSTV. D Boral Capital lowered shares of Plus Therapeutics […]
D. Boral Capital reissued their hold rating on shares of Plus Therapeutics (NASDAQ:PSTV – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a $9.00 price target on the stock. Several other research firms have also issued reports on PSTV. D Boral Capital lowered shares of Plus Therapeutics […]
